DPIIT recognised startup Government of India
Startup India
Trumedis Pharmaceuticals Private Limited - electrnoics in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹42.85 Lakh
▼ 25.51% YoY
Net profit · FY 2025
₹1.68 Lakh
Net margin 3.9%
EBITDA · FY 2025
₹2.45 Lakh
EBITDA margin 5.7%
Authorised capital
₹9.75 Lakh
Registered with MCA
Paid-up capital
₹3.9 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Trumedis Pharmaceuticals Private Limited
Data last updated:
Trumedis Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the repair services segment of the electronics sector. It was incorporated on 27 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2019PTC351943. Its GSTIN is 10AAHCT4012B1Z9 (Bihar).
The company has an authorised share capital of ₹9.75 Lakh and a paid-up capital of ₹3.9 Lakh. It is led by directors Neelesh Kumar and Bhagirath Prasad Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E 44/3 Ground Floor, Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.85 Lakh. For the same year it recorded a net profit of ₹1.68 Lakh (net margin 3.9%) and EBITDA of ₹2.45 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 28% over five years.
The company is associated with 1 brand: Trumedispharma.
For more details, the company can be reached via its website trumedispharma.com.
Company Details of Trumedis Pharmaceuticals Private Limited
CIN U52609DL2019PTC351943
Registration Number 351943
Incorporation Date 27 June 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Trumedis Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressE 44/3 Ground Floor, Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020
- IndustryElectrnoics, Repair Services
Comprehensive company report
Trumedis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals operates one associated brand: Trumedispharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides high-quality allopathic medicines, dietary supplements, and homeopathy for masses. | trumedispharma.com |
Business Activity of Trumedis Pharmaceuticals Private Limited
The main business activity of Trumedis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Trumedis Pharmaceuticals Private Limited FY 2025 filings available
Trumedis Pharmaceuticals Private Limited reported revenue of ₹42.85 Lakh for FY 2025.
Revenue · FY 2025
₹42.85 Lakh
Net profit · FY 2025
₹1.68 Lakh margin 3.9%
EBITDA · FY 2025
₹2.45 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR) of Trumedis Pharmaceuticals Private Limited
Revenue CAGR growth
3 years · compounded
▲ 40%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 220%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Trumedis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.45 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Trumedis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Trumedis Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelesh Kumar Also directs: Sentinel Education LLP, Noxis Food Labs Private Limited | Director | 27 Jun 2019 | 7 Years 3 Months | Current |
| Bhagirath Prasad Sinha | Director | 27 Jun 2019 | 7 Years 3 Months | Current |
Peer Comparison of Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fuhrer Pharmaceuticals Private Limited | ₹42.98 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Lucknow, Uttar Pradesh, India |
| SMV Pharmaceuticals Private Limited | ₹42.95 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Chandigarh, India |
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Mehsana, Gujarat, India |
| Torrey Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2024) | •••• | •••• | 116.0% | •••• | Nagpur, Maharashtra, India |
| Denexo Pharmaceuticals Private Limited | ₹42.9 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Kharghar, Maharashtra, India |
| Trumedis Pharmaceuticals Private Limited this company | ₹42.85 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Wevet Pharmaceuticals Private Limited | ₹42.84 Lakh (FY 2024) | •••• | •••• | 69.0% | •••• | Allahabad, Uttar Pradesh, India |
| Apsis Pharmaceuticals Private Limited | ₹42.81 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Bioluke Pharmaceuticals Private Limited | ₹42.8 Lakh (FY 2025) | •••• | •••• | -27.0% | •••• | Mumbai, Maharashtra, India |
| Rannim Pharmaceuticals Private Limited | ₹42.69 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Gojhariya, Gujarat, India |
| Dnova Pharmaceuticals Private Limited | ₹42.62 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Trumedis Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Trumedis Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Trumedis Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Trumedis Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bhagirath Prasad Sinha was appointed as Director on 27 Jun 2019.
AGM
Trumedis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trumedis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Bhagirath Prasad Sinha was appointed as Director.
Appointed
Neelesh Kumar was appointed as Director.
Incorporation
27 Jun 2019
Trumedis Pharmaceuticals Private Limited was registered on 27 Jun 2019 with Roc Delhi & aged 7 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Trumedis Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Trumedis Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Trumedis Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCT4012B1Z9 | Bihar | Active | 27 Jan 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Trumedis Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trumedis Pharmaceuticals Private Limited
Trumedis Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in repair services, within the electronics industry. It was incorporated on 27 June 2019 (7+ years old) and is registered under CIN U52609DL2019PTC351943.
Trumedis Pharmaceuticals reported revenue of ₹42.85 Lakh for FY 2025.
Trumedis Pharmaceuticals has 2 current directors:
- Neelesh Kumar - Director
- Bhagirath Prasad Sinha - Director
Trumedis Pharmaceuticals reported a net profit of ₹1.68 Lakh (net margin 3.9%) and EBITDA of ₹2.45 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Trumedis Pharmaceuticals is 40% over three years and 28% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Trumedis Pharmaceuticals is 10AAHCT4012B1Z9, registered in Bihar.
The CIN (Corporate Identification Number) of Trumedis Pharmaceuticals is U52609DL2019PTC351943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trumedis Pharmaceuticals was incorporated on 27 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Trumedis Pharmaceuticals by revenue are Fuhrer Pharmaceuticals Private Limited, SMV Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Torrey Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Bhagirath Prasad Sinha was appointed as Director on 27 Jun 2019. Neelesh Kumar was appointed as Director on 27 Jun 2019.
Yes, Trumedis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).